254
Views
10
CrossRef citations to date
0
Altmetric
Editorial

The pharmacotherapy of overactive bladder

, MD PhD
Pages 1003-1005 | Published online: 04 Feb 2011

Bibliography

  • Abrams P, Cardozo L, Fall M, Standardisation Sub-committee of the International Continence Society. The standardization of terminology of lower urinary tract function: report from the standardization sub-committee of the international Continence society. Neurourol Urodyn 2002;21:167-78
  • Stewart WF, Van Rooyen JB, Cundiff GW, Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20(6):327-36
  • Milsom I, Abrams P, Cardozo L, How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. Br J Urol Int 2001;87(9):760-6, Erratum in: Br J Urol Int 2001;88(7):807
  • Irwin DE, Milsom I, Hunskaar S, Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC Study. Eur Urol 2006;50:1306-15
  • Coyne KS, Sexton CC, Irwin DE, The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008;101(11):1388-95
  • Jackson S. The patient with an overactive bladder–symptoms and quality-of-life issues. Urology 1997;50(Suppl 6A):18-22
  • Milsom I. Epidemiology of stress, Urgency, and Mixed incontinence: where do the Boundaries Cross? Eur Urol 2006;16(Suppl 5):842-8
  • Chapple C. Classification of mixed incontinence Eur Urol Supp 2006;5(16):837-41
  • Sears CL, Lewis C, Noel K, Overactive bladder medication adherence when medication is free to patients. J Urol 2010;183(3):1077-81
  • Apostolidis A, Dasgupta P, Denys P, Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunction: a European consensus panel report. Eur Urol 2009;55:100-20
  • Athanasopoulos A. Editorial comment on: incidence and predictors of complications with sacral neuromodulation. Urology 2009;74(1):233

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.